Frontlight ResearchEarly access
Trial site
Clínica Hepatogastro JK
- 10running trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Crohn's disease5 trials
- Ulcerative colitis4 trials
- Obesity2 trials
- Fatty liver disease (MASLD/MASH)1 trial
- Type 1 diabetes1 trial
- Phase
- Phase 25 trials
- Phase 35 trials
- Status
- Recruiting9 trials
- Active, not recruiting1 trial
- Lead sponsor
- Eli Lilly and Company9 trials
- Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)1 trial
Running trials
Recruiting
Recruiting
Recruiting
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Active, not recruiting
A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Crohn's disease4 recruiting
- Ulcerative colitis4 recruiting
- Obesity2 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
- Type 1 diabetes1 recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026